Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Monthly Archives: September 2017

NJEDA Internships Provide Real-World Experience Within New Jersey’s Innovation Ecosystem

Trenton, NJ, September 25, 2017 — As part of its commitment to developing the next generation of technology and life sciences leaders, the New Jersey Economic Development Authority’s (EDA) Technology and Life Sciences (TLS) team offered two college interns the opportunity to experience New Jersey’s vibrant innovation economy firsthand this summer.

The interns benefited from working at the EDA’s Commercialization Center for Innovative Technologies (CCIT) in North Brunswick, a nationally respected incubation facility dedicated to life sciences and biotechnology companies.

EDA summer internships offer college students multi-faceted, real-world learning opportunities designed to prepare them for a fast-paced work environment. Continue reading

PhRMA’s New ‘Let’s Talk About Cost’ Campaign Convenes National Dialogue on Medicine Costs

Washington, DC, September 23, 2017Robert Zirkelbach, Executive Vice President of Public Affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA), in July posted on the association’s blog, The Catalyst:

Discussions about costs are important. We recognize that many are struggling to access the medicine they need and have important questions about their medicine costs.  And we want to help find the answers.

We recognize that many are struggling to access the medicine they need and have important questions about their medicine costs. And we want to help find the answers. Continue reading

SSTI Recognizes Outstanding Initiatives Driving Regional Prosperity, Innovation; NJ Innovation Institute Among 2017 Honorees

Washington, DC, September 22, 2017 — From teaching high school students in rural western Kentucky how to become entrepreneurs to connecting entrepreneurs with a worldwide network of partners in a virtual hub, organizations are finding innovative ways to build regional prosperity.

Four outstanding examples — including New Jersey Innovation Institute’s Health IT Connections program — were recognized September 14 by the State Science & Technology Institute (SSTI), a national organization working to strengthen initiatives to create a better future through science, technology, innovation and entrepreneurship. Continue reading

Rutgers Research: A Fat-Regulating Enzyme Could Hold the Key to Obesity, Diabetes, Cancer, Other Diseases

Dr. George Carman

New Brunswick, NJ, September 21, 2017 — Todd B. Bates reports for Rutgers Today that It had already been known that the enzyme known as phosphatidic acid phosphatase plays a crucial role in regulating the amount of fat in the human body.  Controlling it is therefore of interest in the fight against obesity.

But scientists at Rutgers University-New Brunswick have now found that getting rid of the enzyme entirely can increase the risk of cancer, inflammation and other ills. Their findings were published online in the Journal of Biological Chemistry last month.

“The goal of our lab is to understand how we can tweak and control this enzyme,” said George M. Carman, Ph.D., Board of Governors professor in the Department of Food Science in the School of Environmental and Biological Sciences. Continue reading

Rutgers Business School Team Wins $1 Million Hult Prize; Former President Clinton Presents ‘Nobel Prize for Students’

Former President Bill Clinton presents 2017 Hult Prize to Rutgers team

New Brunswick, NJ, September 21, 2017 — Susan Todd reports that a team representing Rutgers Business School won the $1 million Hult Prize for social entrepreneurship on September 16.

The award, which was announced by former President Bill Clinton, capped off 11 months of entrepreneurial effort with a polished, convincing pitch about the ability of its rickshaw transportation business to improve the lives of refugees overseas.

Student Gia Farooqi, new graduates Hasan Usmani and Moneeb Mian, and alumna Hanaa Lakhani created the Roshni Rides startup as a way of answering the 2017 Hult Prize Challenge of developing a business capable of restoring the dignity of one million refugees by 2022. Continue reading

HINJ Named Among ‘Best Lobbying Firms’ in NJBIZ’s First Readers Rankings Survey

New Brunswick, NJ, September 20, 2017 — The HealthCare Institute of New Jersey (HINJ) was among the New Jersey companies, organizations and universities named in NJBIZ’s inaugural “Readers Rankings” survey.

In a special supplement published with NJBIZ’s September 18 issue, HINJ was named as one of the “Best Lobbying Firms,” along with Gibbons PC, Princeton Public Affairs Group and Public Strategies Impact LLC, with which HINJ tied for #3.

HINJ member companies Johnson & Johnson and Merck & Co., along with Rutgers University, were reader-ranked as the “Best Life Sciences Companies.” Continue reading

Rutgers NJ Medical School Research: Memory Decline After Head Injury May be Prevented by Slowing Brain Cell Growth

New Brunswick, NJ, September 20, 2017 — Robin Lally reports on Rutgers Today that the excessive burst of new brain cells after a traumatic head injury that scientists have traditionally believed helped in recovery could instead lead to epileptic seizures and long-term cognitive decline, according to a new Rutgers New Jersey Medical School study.

In the September issue of Stem Cell Reports, Viji Santhakumar, Ph.D., associate professor in Department of Pharmacology, Physiology and Neuroscience, and her colleagues, challenge the prevailing assumption by scientists in the field that excessive neurogenesis (the birth of new brain cells) after injury is advantageous. Continue reading

Choose New Jersey Program Helps Students Begin Professional Careers Close to Home

Trenton, NJ, September 20, 2017 — While New Jersey colleges and universities are actively building facilities and creating programs to attract and retain students, New Jersey businesses are doing their part, too.

Choose New Jersey, though its Smart Students Choose New Jersey program, is helping high-achieving students who choose to advance their education in-state begin their professional careers close to home.

Thirty New Jersey college students who graduated from high schools in Newark and Camden had the opportunity to intern at businesses and non-profits in the Garden State this summer as part of the Smart Students program. Continue reading

BIO Report Finds Bioscience Drives Economic Growth in States Across U.S.

Washington, DC, September 20, 2017 — A report from Biotechnology Innovation Organization (BIO) unveiled in June concludes that the bioscience industry has had a positive impact on states’ economies and continues to be a driver of economic growth.

According to the new BIO report released in June, state lawmakers have recognized the importance of the industry, the authors state, and have responded to challenges facing the bioscience companies with legislative efforts focused on a supportive business climate. Continue reading

Gov. Christie, Pharma Executives and Federal Leaders Discuss Public-Private Partnership to Address Opioid Epidemic

Governor Chris Christie

Trenton, NJ, September 19, 2017 — Governor Chris Christie, chairman of the President’s Commission on Combating Drug Addiction and the Opioid Crisis, yesterday joined Kellyanne Conway, Counselor to the President, and Former U.S. Rep. Patrick Kennedy, a commission member, in a roundtable at the War Memorial with leaders of the pharmaceutical industry, the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) to advance a public-private partnership that can address America’s epidemic of addiction.

Governor Christie said, “The public and private sectors must join together to address this public health crisis and act quickly to stop an epidemic delivering a death toll equivalent to America enduring another 9-11 attack every two and a half weeks.” Continue reading